FRESH TRACKS THERAPEUTICS IN (FRTX) Stock Balance Sheet
USA - NASDAQ:FRTX - US10802T2042 - Common Stock
0.79 USD
-0.02 (-2.48%)
0.77 USD
-0.02 (-2.53%)
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 12.00M | 8.70M | 26.90M | 30.10M | 7.20M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | 0 | 4.50M | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 1.00M | 1.40M | 2.70M | 3.40M | 6.20M | |||
| Total Current Assets | 13.00M | 10.10M | 29.60M | 33.50M | 18.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0 | 100.00K | 100.00K | 100.00K | 200.00K | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | 0 | |||
| Other Non-Current Assets | null | null | null | null | null | |||
| Total Non-Current Assets | 100.00K | 200.00K | 100.00K | 100.00K | 100.00K | |||
| TOTAL ASSETS | 13.10M | 10.30M | 29.70M | 33.60M | 18.10M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 300.00K | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 1.50M | 2.50M | 3.20M | 5.50M | 6.50M | |||
| Accounts Payable | 600.00K | 600.00K | 1.60M | 600.00K | 2.20M | |||
| Other Current Liabilities | null | null | null | 0 | 1.80M | |||
| Total Current Liabilities | 2.10M | 3.10M | 4.80M | 6.40M | 10.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 100.00K | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | null | null | null | 0 | 100.00K | |||
| Total Non-Current Liabilities | 0 | 0 | 0 | 100.00K | 100.00K | |||
| TOTAL LIABILITIES | 2.10M | 3.10M | 4.80M | 6.50M | 10.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -170.90M | -166.50M | -145.40M | -105.90M | -85.00M | |||
| Additional Paid In Capital | 181.80M | 173.60M | 169.10M | 132.50M | 92.50M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 100.00K | 0 | 1.20M | 500.00K | 100.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | null | null | null | 0 | 0 | |||
| Shares Outstanding | 5.90M | 3.00M | 2.70M | 1.20M | 200.00K | |||
| Tangible Book Value per Share | 1.8475 | 2.4 | 9.2222 | 22.5833 | 38 | |||
| Total Shareholders' Equity | 10.90M | 7.20M | 24.90M | 27.10M | 7.60M | |||
| TOTAL LIABILITIES AND EQUITY | 13.10M | 10.30M | 29.70M | 33.60M | 18.10M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.01 | N/A | |||
| Current Ratio | 6.19 | 3.26 | 6.17 | 5.23 | 1.71 | |||
| Return On Assets (ROA) | -68.63% | -204.85% | -132.90% | -62.23% | -75.14% | |||
| Return On Equity (ROE) | -82.48% | -293.06% | -158.51% | -77.16% | -178.95% | |||
All data in USD , ROIC based on taxRate of 0.21